Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer

British Journal of Cancer

Volumn 100, Issue 5, 2009, Pages 701-706

  Roxburgh, C S D ^a   Crozier, J E M ^a   Maxwell, F ^a   Foulis, A K ^b   Brown, J ^c   McKee, R F ^a   Anderson, J H ^a   Horgan, P G ^a   McMillan, D C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

Colorectal cancer; Curative resection; Glasgow Prognostic Score; Petersen Index; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; DIAGNOSTIC ACCURACY; DUKES' STAGE; EXANTHEMA SUBITUM; FEMALE; FOLLOW UP; GLASGOW PROGNOSTIC SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PETERSEN INDEX; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RESEARCH DESIGN; SURVIVAL ANALYSIS;

EID: 61749090741     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604926     Document Type: Article

References (17)

1. Abramovitch R, Marikovsky M, Meir G, Neeman M (1999) Stimulation of tumour growth by wound-derived growth factors. Br J Cancer 79: 1392-1398
2. Cancerstats (2004) www.cancerresearchuk.org
3. Canna K, Hilmy M, McMillan DC, Smith GW, McKee RF, McArdle CS, McNicol AM (2007) The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Colorectal Dis 10(7): 663-667.
4. Canna K, McArdle PA, McMillan DC, McNicol AM, Smith GW, McKee RF, McArdle CS (2005) The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 92: 651-654
5. Coussens LM, Werb Z. (2002) Inflammation and cancer. Nature 420(6917): 860-867
6. Crozier JEM, Mckee RF, Mcardle CS, Angerson WJ, Anderson JH, Horgan PG, McMillan DC (2006) The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer. Br J Cancer 94(12): 1833-1836
7. Du Klos TW, Mold C (2004) C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol Res 30(3): 261-277
8. Dukes CE, Bussey HJR (1958) The spread of rectal cancer and its effect on prognosis. Br J Cancer 12: 309-320
9. Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ (2003) Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89: 1028-1030
10. Graziano F, Cascinu S (2003) Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough? Ann Oncol 14: 1026-1038
11. Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K (2007) Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246: 1047-1051
12. McArdle CS, Hole DJ (2002) Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation. Br J Cancer 86: 331-335
13. McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 22(8): 81-86
14. Morris EJ, Maughan NJ, Forman D, Quirke P (2007) Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology. Gut 56: 1419-1425
15. Nozoe T, Matsumata T, Sugimachi K (2000) Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol 23(3): 263-266
16. Petersen VC, Baxter KJ, Love SB, Shepherd NA (2002) Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut 51: 65-69
17. Stewart CJR, Morris M, de Boer B, Iacopetta B (2007) Identification of serosal onvasion and extramural venous invasion on review of Dukes' stage B colonic carcinoma and correlation with survival. Histopathology 51: 372-378